Kim SK - Search Results

1

Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment.

Kim H, Im I, Jeon JS, Kang EH, Lee HA, Jo S, Kim JW, Woo DH, Choi YJ, Kim HJ, Han JS, Lee BS, Kim JH, Kim SK, Park HJ. Kim H, et al. Among authors: kim hj, kim sk, kim jw, kim jh. Biomaterials. 2022 Jul;286:121575. doi: 10.1016/j.biomaterials.2022.121575. Epub 2022 May 16. Biomaterials. 2022. PMID: 35598335 Free article.

2

Metabolic characterization of meso-dihydroguaiaretic acid in liver microsomes and in mice.

Jeon JS, Oh SJ, Lee JY, Ryu CS, Kim YM, Lee BH, Kim SK. Jeon JS, et al. Among authors: kim ym, kim sk. Food Chem Toxicol. 2015 Feb;76:94-102. doi: 10.1016/j.fct.2014.12.007. Epub 2014 Dec 19. Food Chem Toxicol. 2015. PMID: 25533794

3

Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.

Choi JM, Oh SJ, Lee JY, Jeon JS, Ryu CS, Kim YM, Lee K, Kim SK. Choi JM, et al. Among authors: kim ym, kim sk. Chem Res Toxicol. 2015 May 18;28(5):872-85. doi: 10.1021/tx500504n. Epub 2015 Apr 17. Chem Res Toxicol. 2015. PMID: 25860621

4

Characterization of fimasartan metabolites in human liver microsomes and human plasma.

Lee JY, Choi YJ, Oh SJ, Chi YH, Paik SH, Lee KH, Jung JK, Ryu CS, Kim KB, Kim DH, Yoon YR, Kim SK. Lee JY, et al. Among authors: kim dh, kim kb, kim sk. Xenobiotica. 2016;46(1):40-51. doi: 10.3109/00498254.2015.1047429. Epub 2015 Jun 11. Xenobiotica. 2016. PMID: 26068523 Clinical Trial.

5

Discovery of enantioselectivity of urea inhibitors of soluble epoxide hydrolase.

Manickam M, Pillaiyar T, Boggu P, Venkateswararao E, Jalani HB, Kim ND, Lee SK, Jeon JS, Kim SK, Jung SH. Manickam M, et al. Among authors: kim nd, kim sk. Eur J Med Chem. 2016 Jul 19;117:113-24. doi: 10.1016/j.ejmech.2016.04.015. Epub 2016 Apr 9. Eur J Med Chem. 2016. PMID: 27092411

6

Hepatic expression of cytochrome P450 in Zucker diabetic fatty rats.

Park SY, Kim CH, Lee JY, Jeon JS, Kim MJ, Chae SH, Kim HC, Oh SJ, Kim SK. Park SY, et al. Among authors: kim ch, kim sk, kim hc, kim mj. Food Chem Toxicol. 2016 Oct;96:244-53. doi: 10.1016/j.fct.2016.08.010. Epub 2016 Aug 11. Food Chem Toxicol. 2016. PMID: 27523289

7

Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys.

Choi WH, Jo HR, Jeon EJ, Youm SY, Jeon JS, Son YG, You WK, Koh WS, Lee SH, Kim SK. Choi WH, et al. Among authors: kim sk. J Pharm Biomed Anal. 2016 Nov 30;131:309-315. doi: 10.1016/j.jpba.2016.09.009. Epub 2016 Sep 5. J Pharm Biomed Anal. 2016. PMID: 27619177

8

Age-Related Changes in Sulfur Amino Acid Metabolism in Male C57BL/6 Mice.

Jeon JS, Oh JJ, Kwak HC, Yun HY, Kim HC, Kim YM, Oh SJ, Kim SK. Jeon JS, et al. Among authors: kim ym, kim sk, kim hc. Biomol Ther (Seoul). 2018 Mar 1;26(2):167-174. doi: 10.4062/biomolther.2017.054. Biomol Ther (Seoul). 2018. PMID: 28605831 Free PMC article.

9

Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer.

Thuy Phuong NT, Kim JW, Kim JA, Jeon JS, Lee JY, Xu WJ, Yang JW, Kim SK, Kang KW. Thuy Phuong NT, et al. Among authors: kim ja, kim sk, kim jw. Oncotarget. 2017 Aug 18;8(41):71054-71069. doi: 10.18632/oncotarget.20329. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050342 Free PMC article.

10

Role of cytochrome P450 enzymes in fimasartan metabolism in vitro.

Choi YJ, Lee JY, Ryu CS, Chi YH, Paik SH, Kim SK. Choi YJ, et al. Among authors: kim sk. Food Chem Toxicol. 2018 May;115:375-384. doi: 10.1016/j.fct.2018.03.036. Epub 2018 Mar 26. Food Chem Toxicol. 2018. PMID: 29596975

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,073 results

Search Page